Overview A type of bone growth disorder. Due to genetic mutations, the cartilage does not convert into a bone during fetal ...

An experimental drug from BridgeBio Pharma helped accelerate growth in height among a dozen people with achondroplasia, the most common cause of disproportionate short stature. The results, from one ...

The high school sports year has come to a close, but a La Costa Canyon High School freshman swimmer is reshaping what is ...

BridgeBio Pharma has bounced back from the withdrawal of infigratinib in oncology, linking the molecule to a BioMarin-beating ...

Today's biotech news update includes a dramatic vote on MDMA therapy, record drug shortages, bad(?) news for Biomarin, and a ...

Mizuho Securities analyst Salim Syed assigned a Buy rating on BridgeBio Pharma (BBIO – Research Report) on June 4 and set a price target ...

Little Johnstons star Liz Johnston revealed her reaction to learning that her daughter, Leighton Drew, is a normal-sized baby ...

For Andrew Hanna, adapting to changing situations on stage teaches him how to adapt to the many challenges in life. The ...

(Exclusive) She also notes that babies with dwarfism or achondroplasia can have "larger than normal" heads. From a birthing perspective, Liz admits that carrying Leighton was "just more bearable ...

Bridgebio Pharma Inc.’s data from the phase II study with infigratinib in achondroplasia “swings the pendulum of debate ...

Snacking on chips and salsa seems pretty simple, but if you’re a person with disabilities at a local establishment, and the ...

Analyst Mani Foroohar of Leerink Partners maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report), with a price target of ...